Effects of melatonin supplementation on oxidative stress: a systematic review and meta-analysis of randomized controlled trials
- 28 September 2020
- journal article
- review article
- Published by Walter de Gruyter GmbH in Hormone Molecular Biology and Clinical Investigation
- Vol. 41 (4)
Abstract
Objectives: Previous studies showed that melatonin supplementation may suppress oxidative stress, however, the results have not been consistent. So, we conducted this meta-analysis to assess the precise relationship between melatonin supplementation and oxidative stress. Methods: PubMed and Scopus were searched for randomized controlled trials that investigated the effect of melatonin supplementation on oxidative stress up to March 2020. Heterogeneity was assessed by Cochran’s Q test and I-square ( I 2 ) statistic. Data were pooled using the random effect model and standardized mean difference (SMD) was considered as the summary effect size. Also, standard methods were used for assessment of sensitivity analysis and publication bias. Results: We included 15 related articles and our findings indicated that melatonin supplementation significantly increased total antioxidant capacity (TAC) level (SMD: 1.03, 95% CI: 0.24, 1.81, p=0.011) and reduced protein carbonyl (PCO) (SMD: −1.78, 95% CI: −2.97, −0.58, p=0.004) and malondialdehyde (MDA) levels (SMD: −0.94, 95% CI: −1.48, −0.40, p=0.001). Additionally, there was considerable effect on TAC level by using ≥20 mg/d melatonin and in people under 35 years old. MDA level also decreased using dosage of below 20 mg/d and in people ≥35 years old. Conclusions: The present study showed a promising effect of melatonin administration for reducing MDA, PCO, and increasing TAC levels. However, further studies especially with more attention to PCO level assessment are needed to confirm the findings of the present study in larger samples on different populations.Keywords
This publication has 48 references indexed in Scilit:
- On the free radical scavenging activities of melatonin's metabolites, AFMK and AMKJournal of Pineal Research, 2012
- Melatonin and its analogs in insomnia and depressionJournal of Pineal Research, 2012
- Oxidative Stress and Antioxidant DefenseWorld Allergy Organization Journal, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signalingJournal of Pineal Research, 2011
- Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesityObesity Reviews, 2011
- Long‐term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2‐diabetic Goto‐Kakizaki ratsJournal of Pineal Research, 2010
- Melatonin improves sleep and reduces nitrite in the exhaled breath condensate in cystic fibrosis – a randomized, double‐blind placebo‐controlled studyJournal of Pineal Research, 2009
- Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal modelInternational Journal of Experimental Pathology, 2006
- Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatmentJournal of Pineal Research, 2000